A PCa xenograft study using another PSMA-targeting second-generation CAR T therapy combined with low doses of docetaxel (an antimicrotubule chemotherapeutic agent) was applied focally and eliminated tumor cells in mice.60 This evidence concerns the gene FOLH1 and neoplasm.